4 completed. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Malignant Paraganglioma: new trials by email Literature Review of Malignant Paraganglioma trials Research Report on Malignant Paraganglioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma anlotinib hydrochloride - Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma | Phase 2 | Completed | Peking Union Medical College Hospital | 27 | 2021-04-30 | 2024-06-12 |
| Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Lenvatinib, Quality-of-Life Assessment - Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma | Phase 2 | Completed | Mayo Clinic | 3 | 2017-05-31 | 2024-02-20 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer Computed Tomography, Dual X-ray Absorptiometry, Physical Examination - Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma | Not applicable | Completed | M.D. Anderson Cancer Center | 23 | 2015-11-16 | 2024-03-05 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
Paraganglioma, Extra-Adrenal (4) · Pheochromocytoma (3) · Carcinoma, Medullary (2) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Islet Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Endometrial Neoplasms (1) · Neoplasm Metastasis (1) · Paraganglioma (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Neuroendocrine Tumors (4) · Paraganglioma (3) · Adenocarcinoma (2) · Carcinoma (2) · Carcinoma, Neuroendocrine (2) · Neoplasms, Ductal, Lobular, and Medullary (2) · Neoplasms, Glandular and Epithelial (2) · Adnexal Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1)
lenvatinib (2) · Absorptiometry, Photon (1) · Restraint, Physical (1) · Sirolimus (1) · Vinorelbine (1) · anlotinib (1) · cabozantinib (1) · temsirolimus (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Peking Union Medical College Hospital (1) · University of Southern California (1)
United States (3) · China (1)
Agustin Garcia (1) · Anli Tong (1) · Ashish Chintakuntlawar (1) · Naifa L Busaidy (1)
P30CA015083 (1)